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Abstract
Objectives: The timing of major elective operations is a potentially important but rarely examined
outcome variable. This study examined elective pancreaticoduodenectomy (PD) timing as a perioperative
outcome variable.
Methods: Consecutive patients submitted to PD were identified. Determinants of 90-day morbidity
(prospectively graded and tracked), anastomotic leak or fistula, and mortality, including operation start
time (time of day), day of week and month, were assessed in univariate and multivariate analyses.
Operation start time was analysed as a continuous and a categorical variable.
Results: Of the 819 patients identified, 405 (49.5%) experienced one or more complications (total
number of events = 684); 90-day mortality was 3.5%. On multivariate analysis, predictors of any morbidity
included male gender (P = 0.009) and estimated blood loss (P = 0.017). Male gender (P = 0.002), benign
diagnosis (P = 0.002), presence of comorbidities (P = 0.002), American Society of Anesthesiologists (ASA)
score (P = 0.025), larger tumour size (P = 0.013) and positive resection margin status (P = 0.005) were
associated with the occurrence of anastomotic leak or fistula. Cardiac and pulmonary comorbidities were
the only variables associated with 90-day mortality. Variables pertaining to procedure scheduling were not
associated with perioperative morbidity or mortality. Operation start time was not significant when
analysed as a continuous or a categorical variable, or when stratified by surgeon.
Conclusions: Perioperative outcome after PD is determined by patient, disease and operative factors
and does not appear to be influenced by procedure timing.
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Introduction
In surgery, operator fatigue and experience, as well as the avail-
ability of appropriate supervision and assistance, may potentially
influence perioperative outcomes. Concerns have been raised
about possible variations in quality of care and increased compli-
cation rates as a result of the timing of surgical procedures. Several
studies have suggested variability in the outcomes of operations
based on the month of the year, day of the week and time of day
at which they take place.
The ‘July effect’, used to describe the impact of the annual
arrival of new housestaff in July, has been extensively researched,
with conflicting results. A 2007 National Surgical Quality
Improvement Program (NSQIP) study reported seasonal varia-
tion marked by significant increases in operative morbidity and
mortality in the earlier months of the academic year,1 and a more
recent study showed higher intraoperative complication and mor-
tality rates in patients undergoing surgery for spinal metastases at
teaching hospitals in the month of July.2 These data contrast with
the results of several studies showing no differences in the out-
comes of surgeries performed at the beginning of the academic
year compared with those performed at other times.3–5 Data on
outcomes according to the time of day at which procedures are
performed have been similarly contradictory.6–9
Pancreaticoduodenectomy (PD) is among the more demanding
and complex procedures in gastrointestinal surgery. Since
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Whipple et al.’s 1935 report,10 PD has evolved from a high-risk,
resource-intensive endeavour to a commonly performed opera-
tion of which good outcomes are expected for most patients.
Perioperative mortality has declined to <5%, although morbidity
rates remain in the range of 30–65%.11 Infectious complications,
particularly related to anastomotic leaks and fistulae, remain the
major source of morbidity and are associated with intra-
abdominal haemorrhage and sepsis.11 Perioperative morbidity is
associated with greater hospital length of stay (LoS), higher costs
and, in patients with malignant disease, delay in the initiation of
adjuvant therapy and potentially reduced survival. Several studies
have suggested that perioperative morbidity has an adverse impact
on cancer-specific survival.12–14
Many factors contribute to perioperative morbidity, including
patient-related (underlying diagnosis, pre-existing comorbidi-
ties), surgeon-related (experience) and institution-related (high-
versus low-volume) variables. However, the impact of the timing
of the procedure has not been fully investigated in outcome analy-
ses.15 This study represents a single-institution analysis of con-
secutive patients undergoing PD and specifically addresses the
impacts of operation scheduling (month of the year, day of the
week and time of day) on perioperative morbidity and mortality.
Materials and methods
Subjects and data collection
This study was approved by the institutional review board at
Memorial Sloan–Kettering Cancer Center (MSKCC); compliance
with the Health Insurance Portability and Accountability Act
(HIPAA) was assured. Data for patients submitted to PD for any
diagnosis were analysed. Data were collected from electronic
medical records and included clinical and pathological data, pro-
cedure performed (standard versus pylorus-preserving PD),
pathological margin status, duration of operation, estimated
blood loss (EBL), postoperative LoS, surgical schedule distribu-
tion, 90-day complications and 90-day mortality. The study popu-
lation was analysed by age, gender, presence of a benign or
malignant neoplasm, diagnosis, tumour size, presence of comor-
bidities [hypertension, cardiac disease, diabetes mellitus (DM),
pulmonary disease, other comorbidities], body mass index (BMI)
and American Society of Anesthesiologists (ASA) physical status
score.16 Patients were divided by diagnosis into two groups repre-
sented by, respectively, malignant neoplasms [adenocarcinoma,
gastrointestinal stromal tumour (GIST), endocrine tumours], and
benign disease (cystic lesions and solid adenomas). It should be
noted that the great majority of patients were referred to MSKCC
after they had undergone biliary decompression.
Operative approach
All patients included in the study underwent either a standard or
a pylorus-preserving PD at the discretion of the attending sur-
geon.17 Extended resections, including of adjacent organs or
extensive retroperitoneal lymph node dissections, were not per-
formed routinely; portal vein resection or reconstruction was
performed as needed. Duct-to-mucosa end-to-side pancreaticoje-
junostomy was used to reconstruct the pancreatic remnant in
nearly all patients. Patients operated by surgeons who performed
fewer than 45 resections over the entire study period were
excluded in order to exclude ‘the learning curve’ effect as a poten-
tial confounding variable. After surgery, patients recovered over-
night in the post-anaesthesia care unit and were transferred to the
regular surgical ward the following morning; transfer to the inten-
sive care unit (ICU) was reserved for critically ill patients and was
required in <5% of patients at any time in their course.
Surgical timing and scheduling
Surgical scheduling was categorized and analysed by month of the
year, day of the week and time of day at which the procedure
started (surgical start time). Surgical start time was analysed as a
continuous variable and as a categorical variable (morning versus
afternoon and in 4-h time periods). Surgeons whose patients were
included in this study were assigned one or more full days of block
time for surgery on the same day or days of the week and generally
started between 07.30 h and 08.30 h and continued until the oper-
ating list had been completed. During the study period, operating
room start time was generally 60–90 min later on Mondays and
Wednesdays to accommodate educational conferences. The
potential influence of surgical start time on perioperative
outcome was analysed for all surgeons collectively and for each
surgeon individually.
Complications
All postoperative complications were prospectively recorded in a
departmental database and graded in severity using a score of 1–5,
based on a grading system devised in 1999.18 The definition of
postoperative pancreatic fistula (POPF) included pancreatic anas-
tomotic leak (i.e. clinical signs and symptoms or radiologic con-
firmation of pancreatic anastomotic leak with amylase-rich
drainage of >50 ml/day beyond postoperative day 5, without
development of a fistula), pancreatic fistula (i.e. clinical signs and
symptoms with amylase-rich drainage of >50 ml/day beyond
postoperative day 10), and intra-abdominal abscess (i.e. clinical
signs and symptoms or radiologic diagnosis of intra-abdominal
abscess or peritonitis), as previously described.19 The POPF clas-
sification by the International Study Group on Pancreatic Fistula
(ISGPF) was used to grade POPF.20
Statistical analysis
Values were expressed as medians (with interquartile ranges), or
percentages, as appropriate. Statistical analyses were performed
using Fisher’s exact test and the Wilcoxon rank sum test to
examine covariate differences between patients with and without
complications, patients with and without leaks and fistulae, and
patients deceased and alive at 90 days after surgery. Based on the
sample size, a power calculation was performed to determine the
level of difference detectable in complication rate. Subsequent to
the univariate analysis, a logistic regression model was developed
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to determine the set of factors that independently predicted each
of the three outcomes. Hospital LoS was analysed by Wilcoxon
rank sum and Kruskal–Wallis tests regarding differences in opera-
tion time distribution. Factors that were significantly associated
with complications in univariate analysis (inclusion criterion: P
0.1) were entered into a multivariate analysis to test for significant
effects while adjusting for possible confounders. A P-value of
<0.05 was considered to indicate statistical significance in univari-
ate and multivariate analyses. Sample size calculation was per-
formed to avoid type II error (b = 0.2), looking for expected
proportional variation of 10% according to surgical start time of
day (before and after 12.00 h) and day of week. All statistical
analyses were conducted using stata Version 8.0 (StataCorp LP,
College Station, TX, USA).
Results
During 2000–2008, 819 consecutive patients underwent PD per-
formed by eight surgeons, each of whom performed at least 45
procedures during the study period. A total of 405 patients
(49.5%) experienced one or more perioperative complications
(total number of events = 684); the 90-day mortality for all causes
(i.e. grade 5 complications) was 3.5%. Clinicopathological and
operative data are outlined in Table 1. The population studied
included 401 (49.0%) female and 418 (51.0%) male patients with
a mean age at the date of operation of 66 12 years (range: 29–92
years; median: 67 years). Significant differences in the presence of
comorbidities between the groups with and without complica-
tions emerged only for cardiac disease (26.4% versus 19.8%,
respectively; P = 0.025) and BMI (median: 27 kg/m2 versus 26 kg/
m2, respectively; P = 0.002); no significant differences were noted
for other comorbidities. Regarding the diagnoses, 701 (85.6%)
lesions were malignant and 118 (14.4%) were benign. The mean
tumour size was 3.1  2.1 cm (range: 0–43.5 cm; median:
2.9 cm). Standard PD was performed in 84.1% of patients. The
mean duration of surgery was 273 73 min (range: 101–558 min;
median: 266 min). The mean EBL during surgery was 727 
656 ml (range: 50–8500 ml; median: 600 ml). The mean LoS was
12.5  10.6 days (range: 1–133 days; median: 9 days).
The distribution of complications, by system, is presented in
Table 2(a), which shows the percentages of patients who experi-
enced any complication, any high-grade complication (grades
3–5) and who died within 90 days stratified by organ system.
Gastrointestinal complications were the most common, account-
ing for 32.6% (223 of 684 recorded events) of total morbidity,
followed by infectious complications at 19.7% (135 of 684
recorded events). In patients with higher-grade complications, the
gastrointestinal system was again the most common source,
accounting for 34.5% (91 of 264) of recorded events, and cardio-
vascular or pulmonary events were most commonly associated
with 90-day mortality (24.1% for each).
Table 2(b) summarizes the complications related to biliary,
intestinal, chylous and pancreatic leaks and fistulae and the sub-
group of pancreatic fistulae classified by ISGPF criteria. The
overall incidence of POPF was 12.7% (104 in 819 patients); 34
(32.7%) occurred in men and 70 (67.3%) in women. The mean
age of this group was 66 18 years, and 78 (75.0%) patients had
a malignant diagnosis compared with 26 (25.0%) with benign
disease. The mean size of tumours was 2.7 2.1 cm and the mean
EBL during surgery was 787  656 ml; median LoS for patients
with pancreatic leaks or fistulae was 10 days (range: 7–122 days).
In the subgroup of patients with pancreatic leaks or fistulae, 71
operations (68.3%) started before 12.00 h and 33 (31.7%) after
12.00 h.On univariate analysis, neither time of day (12.7% in each
group starting before or after 12.00 h; P = 1.000), nor day of the
week (Mondays, 12.8%; Tuesdays, 11.0%, Wednesdays, 21.2%;
Thursdays, 13.2%; Fridays, 9.0%; P = 0.080), nor month of year
(ranging from 5.7% to 18.6%; P = 0.570) had any impact on the
incidence of this complication.
Surgical scheduling data for the complication and
no-complication groups are shown in Table 3 and Fig. 1. Over the
9-year period, the mean number of operations per month was 7.6
 3.1 and the mean number of complications was 3.8  2.1; the
total number of resections for each calendar month (January–
December ¥ 9 years of the study period) ranged from 50 to 80 and
the number of complications ranged from 22 to 42. Total compli-
cations, leak and fistula rates, and death within 90 days did not
differ significantly in any particular month of the year when ana-
lysed as trends (P = 0.920, P = 0.715 and P = 0.736, respectively),
as demonstrated in Fig. 1(a). This was also true when data for each
month of the year were analysed separately (P-values for each
month of the year ranged from 0.190 to 1.000 for complications,
0.210 to 1.000 for leaks and fistulae, and 0.093 to 1.000 for death
within 90 days). Of note, data for July and August did not differ
from data for the other months: incidences of any complications
were 51.3% and 49.0%, respectively (P = 0.652); incidences of
high-grade complications (grades 3–5) were 24.0% and 21.2%,
respectively (P = 0.445); incidences of leak or fistula were 16.0%
and 16.1%, respectively (P = 1.000); procedure duration was
275 min and 265 min, respectively (P = 0.194); median EBL
amounted to 600 ml and 580 ml, respectively (P = 0.053), and
death within 90 days occurred in 4.0% and 3.4% of patients,
respectively (P = 0.806).
A median of two operations were performed per week (range:
1–7 operations) and a median of one operation was performed
per surgical day (Mondays–Fridays; range: 1–4 operations). Over
the study period, the number of operations per specific day of the
week ranged from 94 to 309 (Mondays–Fridays over 9 years), and
numbers of complications ranged from 49 to 150. The median
LoS subsequent to surgeries performed onMondays–Wednesdays,
and surgeries performed on Thursdays and Fridays was 9 days in
both cases (P = 0.626); an analysis of weekdays individually
showed that median LoS varied between 9 days and 10 days (P =
0.012). The median LoS after surgery performed in July and
August was 1 day longer than that after surgery performed in
September–June (10 days versus 9 days; P = 0.024); however, when
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Table 1 Clinicopathological and operative variables
Variable All patients (n = 819) Complications P-value
Yes
(n = 405, 49.5%)
No
(n = 414, 50.5%)
Age, years, median (IQR) 67 (58–75) 67 (59–76) 68 (57–75) 0.638
Sex, n (%) <0.001
Female 401 (49.0%) 171 (42.2%) 230 (55.5%)
Male 418 (51.0%) 234 (57.8%) 184 (44.5%)
Body mass index, kg/m2, median (IQR) 26.4 (23.4–29.7) 27.0 (23.8–30.5) 25.8 (22.8–29.2) 0.002
Hypertension, n (%) 392 (47.9%) 199 (49.1%) 193 (46.6%) 0.485
Diabetes mellitus, n (%) 157 (19.2%) 76 (18.8%) 81 (19.6%) 0.790
Cardiac disease, n (%) 189 (23.1%) 107 (26.4%) 82 (19.8%) 0.025
Pulmonary disease, n (%) 80 (9.8%) 47 (11.6%) 33 (8.0%) 0.099
Other comorbidities, n (%) 533 (65.1%) 258 (63.7%) 275 (66.4%) 0.421
ASA physical status, n (%) 0.106
Class 1 17 (2.1%) 6 (1.5%) 11 (2.7%)
Class 2 422 (51.5%) 201 (49.6%) 221 (53.4%)
Class 3 370 (45.2%) 190 (46.9%) 181 (43.7%)
Class 4 10 (1.2%) 8 (2.0%) 2 (0.5%)
Greatest diameter of tumour, cm, median (IQR) 782 (95.5%)a 2.8 (2.0–3.6) 3.0 (2.0–3.8) 0.140
Malignant tumoursb, n (%) 701 (85.6%) 342 (48.8%) 359 (51.2%) 0.319
Diagnosis, n (%)
Ampulla of Vater
Adenocarcinoma 139 (17.0%) 74 (18.3%) 65 (15.7%)
Adenoma 8 (1.0%) 3 (0.7%) 5 (1.2%)
Neuroendocrine tumour 3 (0.4%) 1 (0.2%) 2 (0.5%)
Others 4 (0.5%) 2 (0.5%) 2 (0.5%)
Bile duct
Adenocarcinoma 55 (6.7%) 33 (8.1%) 22 (5.3%)
Neuroendocrine tumour 1 (0.1%) 1 (0.2%) 0
Others 7 (0.9%) 5 (1.2%) 2 (0.5%)
Duodenum
Adenocarcinoma 55 (6.7%) 28 (6.9%) 27 (6.5%)
Adenoma 9 (1.1%) 5 (1.2%) 4 (1.0%)
GIST 6 (0.7%) 5 (1.2%) 1 (0.2%)
Neuroendocrine tumour 4 (0.5%) 2 (0.5%) 2 (0.5%)
Others 1 (0.1%) 1 (0.2%) 0
Pancreas
Adenocarcinoma 437 (53.4%) 197 (48.6%) 240 (58.0%)
Cystadenoma 23 (2.8%) 14 (3.5%) 9 (2.2%)
Neuroendocrine tumour 36 (4.4%) 22 (5.4%) 14 (3.4%)
Pancreatitis 19 (2.3%) 7 (1.7%) 12 (2.9%)
Others 12 (1.5%) 5 (1.2%) 7 (1.7%)
Procedure, n (%)
Standard PD 689 (84.1%) 343 (49.8%) 346 (50.2%) 0.702
Pylorus-preserving PD 130 (15.9%) 62 (47.7%) 68 (52.3%)
Duration of surgery, min, median (IQR) 266 (221–322) 276 (226–330) 261 (217–313) 0.005
Estimated blood loss, ml, median (IQR) 600 (400–900) 600 (400–1000) 500 (350–800) 0.001
Length of stay, days, median (IQR) 9 (8–13) 12 (9–18) 9 (7–10)
Any positive margins, n (%) 135 (16.5%) 58 (14.3%) 77 (18.6%) 0.109
aThe total number of the measureable tumours was 782.
bMalignant tumours were confirmed by pathology in 701 patients.
ASA, American Society of Anesthesiologists; GIST, gastrointestinal stromal tumour; IQR, interquartile range; PD, pancreaticoduodenectomy.
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all months were analysed as multi-categorical variables, no signifi-
cant difference in LoS was noted (P = 0.270). Day of the week had
no impact on perioperative outcome, including overall complica-
tion rate (52.1%, 48.6%, 58.7%, 45.8% and 47.5% for Mondays to
Fridays, respectively; P = 0.279), high-grade (grades 3–5) compli-
cation rate (21.3%, 21.4%, 26.9%, 21.1% and 19.7% for Mondays
to Fridays, respectively; P = 0.736), pancreatic leak or fistula rate
(12.8%, 14.5%, 25.0%, 17.4% and 13.1% for Mondays to Fridays,
respectively; P = 0.097), median EBL (600 ml, 600 ml, 500 ml,
600 ml and 500 ml for Mondays to Fridays, respectively; P =
0.469), or 90-day mortality (3.2%, 4.5%, 0.6%, 5.3% and 0.6% for
Mondays to Fridays, respectively; P = 0.114) (Fig. 1b). The proce-
dure duration was longer by a median of 17 min for operations
starting later in the day (262 min before 12.00 h and 279 min after
12.00 h; P = 0.021), and there was also some variation by day of
the week (280 min, 261 min, 291 min, 230 min and 305 min for
Mondays to Fridays, respectively; P < 0.001); however, procedure
duration did not differ according to month of the year (medians
ranged from 244 min to 290 min; P = 0.589).
Themajority of operations were started before 12.00 h (n = 559,
68.3%) rather than at or after 12.00 h (n = 260, 31.7%). Overall
morbidity didnot differ betweenoperations started in themorning
and operations started in the afternoon (P = 0.500): high-grade
(grades 3–5) complication rates were 23.6% and 17.7%, respec-
tively (P = 0.057); rates of leak or fistula were 16.5% and 15.4%,
respectively (P = 0.760), and rates of operativemortality were 3.8%
and 3.1%, respectively (P = 0.690) (Fig. 1c). Operation start time
was stratified into three time periods (07.00–11.00 h, 11.01–
15.00 h, 15.01 h and later). The majority (60.9%) of operations
were found to start early in the day. Despite some slight variations
in morbidity rates, no significant differences in overall morbidity
were seen (07.00–11.00 h: P = 0.063; 11.01–15.00 h: P = 0.054;
15.01 h and later: P = 1.000) (Table 3). Of particular note, opera-
tions starting late in the day (i.e. after 15.00 h) were not associated
with greater morbidity, including presence of any complications
(50.0% versus 49.2%; P = 1.000), presence of high-grade compli-
cations (17.4% versus 22.0%; P = 0.582), rates of leak or fistula
(17.4% versus 16.0%; P = 0.836), EBL (600 ml versus 500 ml;
P = 0.056), and deathwithin 90 days (6.5% versus 3.4%;P = 0.219).
Clinicopathological and operative parameters stratified by
operation start time are shown in Table 4. The procedure duration
was slightly shorter for operations startedprior to 12.00 h (median:
262 min; range: 134–470 min) compared with those started after
12.00 h (median: 279 min; range: 121–452 min) (P = 0.020).
Table 2 (a) Morbidity and 90-day mortality in the 405 patients with complications by organ system. (b) Rates of leaks and fistulae
(a) System All complications, n (%) Grade 3–5 complications, n (%) 90-day mortality, n (%)
Gastrointestinal 223 (32.6%) 91 (34.5%) 4 (13.8%)
Infection 135 (19.7%) 89 (33.7%) 2 (6.9%)
Wound or skin 114 (16.7%) 7 (2.7%) 1 (3.5%)
Haematologic/vascular 52 (7.6%) 19 (7.2%) 0
Cardiovascular 50 (7.3%) 12 (4.5%) 7 (24.1%)
Pulmonary 49 (7.2%) 25 (9.5%) 7 (24.1%)
Generala 25 (3.7%) 13 (4.9%) 4 (13.8%)
Genitourinary 15 (2.2%) 3 (1.1%) 0
Nervous system 12 (1.8%) 3 (1.1%) 0
Metabolic 5 (0.7%) 2 (0.8%) 0
Pain 2 (0.3%) 0 0
Endocrine 1 (0.1%) 0 0
Musculoskeletal 1 (0.1%) 0 0
Other causes 0 0 4 (13.8%)
Recorded events, n 684 264 29
(b) Leaks and fistulae
Pancreatic 104 (77.6%)
Biliary 21 (15.7%)
Intestinal 6 (4.5%) POPF classification (ISGPF)
Biliary/pancreatic 2 (1.5%) A B C
Chylous 1 (0.7%) 12 (11.5%) 29 (27.9%) 63 (60.6%)
Recorded events, n 134 104
aThe ‘General’ group includes non-infected intra-abdominal or thoracic collections (n = 11), dehydration (n = 7), death caused by progression of
disease (n = 4), allergic reaction (n = 1), ascites (n = 1) and chyle leak (n = 1).
ISGPF, International Study Group on Pancreatic Fistula; POPF, postoperative pancreatic fistula.
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Hypertension was more common in patients who underwent
surgery after 12.00 h (53.1%) compared with those in whom
surgery began before 12.00 h (45.4%) (P = 0.043). However, all
other variables, including age, gender, BMI, DM, cardiac disease,
pulmonary disease, tumour size, margin status and EBL did not
differ between the groups. Median LoS was 1 day longer after
operations started after 12.00 h (9 days versus 10 days; P = 0.002).
When the surgical start time as a continuous variable was analysed
for all complications, leaks and fistulae, and 90-day mortality, no
significant differences were found (P = 0.905, P = 0.405 and P =
0.695, respectively). Furthermore, the operation start time (before
or after 12.00 h) hadno impact onoverall complication rate, rate of
leak or fistula, or 90-day mortality when analysed for individual
surgeons. The number of events in patients in whom surgery
commenced after 12.00 h, analysed as a continuous variable, is
demonstrated in Fig. 2, which shows a homogeneous distribution.
Univariate and multivariate analyses of morbidity and mortal-
ity are shown in Table 5. Several significant differences were noted
between patients with and without any complications, including
in gender (P < 0.001), BMI of >25 kg/m2 (P = 0.017), cardiac
disease (P = 0.025), duration of operation (P = 0.005), and EBL (P
= 0.001); however, only male gender [odds ratio (OR) = 1.48, 95%
confidence interval (CI) 1.10–1.97; P = 0.009)] and EBL (OR =
1.03, 95% CI 1.01–1.06; P = 0.017) remained significant on mul-
tivariate analysis. Of note, none of the variables pertaining to the
timing of surgery (month of the year, day of the week, time of day)
showed any trend toward significance. With respect to anasto-
motic leaks and fistulae, independent predictors included male
gender (OR = 2.0, 95% CI 1.29–3.10; P = 0.002), other comorbidi-
ties (OR = 0.51, 95% CI 0.34–0.79; P = 0.002), ASA score (OR =
0.63, 95% CI 1.06–2.50; P = 0.025), tumour diameter (OR = 0.83,
95% CI 0.72–0.96; P = 0.013), malignant diagnosis (OR = 0.44,
95% CI 0.26–0.74; P = 0.002), and resection margin status (OR =
0.13, 95% CI 0.03–0.53; P = 0.005). A BMI of >25 kg/m2 (P =
0.707), duration of operation (P = 0.492) and EBL (P = 0.084),
although significant on univariate analysis, did not emerge as
predictive factors in the multivariate model and, once again, vari-
ables related to surgical scheduling played no role. Factors associ-
ated with 90-day mortality were related to age (P = 0.013),
previous cardiac (P = 0.003) and pulmonary (P = 0.055) disease,
Table 3 Scheduling of operations by month, day of the week and time of day and impacts on morbidity
Variable All patients
(n = 819)
Complications P-value
Yes (n = 405, 49.5%) No (n = 414, 50.5%)
Operations by month, mean  SD 7.6  3.1 3.8  2.1 3.8  2.0 0.920
January, n (%) 64 (7.8%) 37 (57.8%) 27 (42.2%)
February, n (%) 70 (8.5%) 33 (47.1%) 37 (52.9%)
March, n (%) 68 (8.3%) 34 (50.0%) 34 (50.0%)
April, n (%) 71 (8.7%) 37 (52.1%) 34 (47.9%)
May, n (%) 76 (9.3%) 36 (47.4%) 40 (52.6%)
June, n (%) 69 (8.4%) 32 (46.4%) 37 (53.6%)
July, n (%) 70 (8.5%) 36 (51.4%) 34 (48.6%)
August, n (%) 80 (9.8%) 41 (51.3%) 39 (48.8%)
September, n (%) 71 (8.7%) 35 (49.3%) 36 (50.7%)
October, n (%) 50 (6.1%) 22 (44.0%) 28 (56.0%)
November, n (%) 59 (7.2%) 24 (40.7%) 35 (59.3%)
December, n (%) 71 (8.7%) 38 (53.5%) 33 (46.5%)
Operations by working day, n (%) 0.279
Monday 94 (11.5%) 49 (52.1%) 45 (47.9%)
Tuesday 309 (37.7%) 150 (48.5%) 159 (51.5%)
Wednesday 104 (12.7%) 61 (58.7%) 43 (41.3%)
Thursday 190 (23.2%) 87 (45.8%) 103 (54.2%)
Friday 122 (14.9%) 58 (47.5%) 64 (52.5%)
Operation start time, n (%)
Before 12.00 h 559 (68.3%) 281 (50.3%) 278 (49.7%) 0.500
12.00 h and later 260 (31.7%) 124 (47.7%) 136 (52.3%)
07.00–11.00 h 499 (60.9%) 260 (52.1%) 239 (47.9%) 0.063
11.01–15.00 h 274 (33.5%) 122 (44.5%) 152 (55.5%) 0.054
15.01 h and later 46 (5.6%) 23 (50.0%) 23 (50.0%) 1.000
SD, standard deviation.
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Figure 1 Distribution of 819 pancreaticoduodenectomies according to surgical scheduling in the 9-year period studied (2000–2008).
(a) Distribution of operations, related postoperative complications, leaks and 90-day mortality stratified by month (P = 0.920, P = 0.715 and
P = 0.736, respectively). (b) Frequency of postoperative complications, leaks and fistulae, and 90-day mortality stratified by day of the week
(P = 0.279, P = 0.097 and P = 0.114, respectively). (c) Number of operations, associated complications, leaks or fistulae, and 90-day mortality
stratified by start time (prior to or after 12.00 h) (P = 0.057, P = 0.760 and P = 0.690, respectively)
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and ASA score (P = 0.001). In the multivariate model, only the
presence of cardiac disease (OR = 2.03, 95% CI 0.89–4.58; P =
0.09) showed borderline significance for increased risk for death.
Body mass index as a continuous variable was significantly asso-
ciated with any complication (P = 0.002) and anastomotic leaks
and fistulae (P = 0.006) on univariate analysis, but not in the
multivariate model (P = 0.870 and P = 0.830, respectively).
Given the sample size of 819 patients and a 50% complication
rate, this analysis had an 80% power to detect a difference of
10% between groups defined by the surgical start time. For
example, if the true underlying complication rates were 45% for
morning operations and 55% for afternoon operations, this study
had sufficient power to find them to be significantly different. The
sample size also provided an 80% power to detect a difference of
8% in complication rates by day of the week. Power analysis for
month of the year was not possible because of the number of
categories (12 months of the year).
Discussion
Work hours and workers’ schedules, and their impact on quality
and safety in the workplace, are major societal concerns. In a study
Table 4 Clinicopathological and operative characteristics stratified by start time (before and after 12.00 h)
Characteristic Before 12.00 h
(n = 559, 68.3%)
12.00 h and later
(n = 260, 31.7%)
Total (n = 819) P-value
Age, years, median (IQR) 67 (58–75) 68 (58–76) 0.292
Sex, n (%) 0.261
Female 266 (47.6%) 135 (51.9%) 401 (49.0%)
Male 293 (52.4%) 125 (48.1%) 418 (51.0%)
Body mass index, kg/m2, median (IQR) 26.3 (23.4–29.7) 26.8 (23.4–29.2) 26.4 (23.4–29.7) 0.792
Hypertension, n (%) 254 (45.4%) 138 (53.1%) 392 (47.9%) 0.043
Diabetes mellitus, n (%) 97 (17.4%) 60 (23.1%) 157 (19.2%) 0.057
Cardiac disease, n (%) 123 (22.0%) 66 (25.4%) 189 (23.1%) 0.286
Pulmonary disease, n (%) 49 (8.8%) 31 (11.9%) 80 (9.8%) 0.165
Other comorbidities, n (%) 373 (66.7%) 160 (61.5%) 533 (65.1%) 0.157
ASA physical status, n (%) 0.432
Class 1 10 (1.8%) 7 (2.7%) 17 (2.1%)
Class 2 296 (53.0%) 126 (48.5%) 422 (51.5%)
Class 3 245 (43.8%) 125 (48.1%) 370 (45.2%)
Class 4 8 (1.4%) 2 (0.8%) 10 (1.2%)
Greatest diameter of tumour, cm, median (IQR) 2.9 (2.0–3.8) 2.9 (2.0–3.6) 2.9 (2.0–3.7) 0.959
Neoplasm, n (%) 0.285
Malignant 473 (84.6%) 228 (87.7%) 701 (85.6%)
Benign and others 86 (15.4%) 32 (12.3%) 118 (14.4%)
Procedure, n (%) 0.918
PD 471 (84.3%) 218 (83.8%) 689 (84.1%)
Pylorus-preserving PD 88 (15.7%) 42 (16.1%) 130 (15.9%)
Duration of operation, min, median (IQR) 262 (218–317) 279 (205–330) 266 (221–322) 0.021
Estimated blood loss, ml, median (IQR) 600 (400–900) 600 (350–900) 600 (400–900) 0.671
Length of stay, days, median (IQR) 9 (8–12) 10 (8–14) 9 (8–13) 0.002
Any positive margins, n (%) 93 (16.6%) 42 (16.2%) 135 (16.5%) 0.920
Highest grade complications, n (%) 0.267
No complications 278 (49.7%) 136 (52.3%) 414 (50.5%)
Grade 1 85 (15.2%) 40 (15.4%) 125 (15.3%)
Grade 2 64 (11.4%) 38 (14.6%) 102 (12.5%)
Grade 3 110 (19.7%) 37 (14.2%) 147 (17.9%)
Grade 4 3 (0.5%) 3 (1.2%) 6 (0.7%)
Grade 5 19 (3.4%) 6 (2.3%) 25 (3.1%)
ASA, American Society of Anesthesiologists; IQR, interquartile range.
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of 7577 German workers, Hänecke et al. described the rate of
work-related errors and suggested an association with duration of
work day and time of day.21 Other studies have suggested that the
performances of airline pilots22,23 and night shift engineers24 are
related not only to hours worked, but also to the circadian cycle.
Limiting work hours to meet health and safety requirements has
also been applied to the practice of medicine and the training of
resident physicians. Concerns regarding medical error were a
major reason for the reduction in resident work hours mandated
by the Accreditation Council for Graduate Medical Education
(ACGME). The effect on patient safety of restricting residents’
work hours remains controversial, with little clear evidence of a
positive impact. Naylor et al. evaluated 275 patients undergoing
emergency cholecystectomy before and after duty hour regula-
tions instituted by the ACGME and suggested that duty hour
restrictions might not have a measurable influence on the surgical
complication rate.25
The explanation for the ‘July phenomenon’ described by Eng-
lesbe et al. referred to the cyclic influx of inexperienced trainees
each July and the lack of oversight by attending physicians.1
Whether this phenomenon is real or not remains the subject of
debate, as the published data are contradictory. In 1993, Rich et al.
analysed 240 467 hospital admissions in two metropolitan areas
during 1983–1987 and showed that in the subset of patients with
internal medicine diagnoses, a ‘July phenomenon’ was observed,
whereby significant decreases in costs for diagnostic tests and
medications in teaching hospitals occurred over the academic
year; however, in patients with surgical diagnoses, the opposite
trend was observed.26 More recently, van Walraven et al. analysed
the influence of housestaff experience on teaching hospital mor-
tality by studying 164 318 patients in a single academic institution
and found no association between the arrival of new housestaff
and the adjusted risk for death in hospital.27 Similarly, two 2003
studies in the ICU and obstetric settings found no such evidence,
All complications No complicationsDeath within 90 daysLeaks and fistulae
18.45 h
18.30 h
18.15 h
18.00 h
17.45 h
17.30 h
17.15 h
17.00 h
16.45 h
16.30 h
16.15 h
16.00 h
15.45 h
15.30 h
15.15 h
15.00 h
14.45 h
14.30 h
14.15 h
14.00 h
13.45 h
13.30 h
13.15 h
13.00 h
12.45 h
12.30 h
12.15 h
12.00 h
O
pe
ra
tio
n 
st
ar
t t
im
es
 a
t 1
2.
00
 h
 a
nd
 la
te
r
Figure 2 Perioperative outcomes of 260 pancreaticoduodenectomies with surgical start times after 12.00 h. Patients are stratified by
perioperative outcomes of any complication, leaks or fistulae, mortality within 90 days, and no complications (P = 0.731, P = 0.489 and
P = 0.345, respectively)
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possibly as a result of the presence of round-the-clock staffing.28,29
In 2006, two neurosurgical studies showed that there was either a
negligible effect of placing shunts during the summer months, or
no effect at all.30,31 A 2008 study by Dhaliwal et al. also showed no
increase in adverse outcomes following cardiac surgery at the
beginning of the academic cycle.32 More recently, however, Dasen-
brock et al. analysed a nationwide sample of 2920 patients admit-
ted with spinal metastases and found significantly higher
inpatient mortality and operative complications in patients
admitted during the month of July.2
Variation in postoperative outcomes has been evaluated by not
only time of year, but also by day of the week and time of day. Zare
et al. described the differences in morbidity and mortality among
different days of the week, showing increased mortality in opera-
tions performed on Fridays, compared with those performed on
Mondays–Thursdays.33 The authors suggested that in patients
admitted to regular hospital floors after non-emergent major
surgery, mortality was increased if surgery was performed on a
Friday rather than earlier in the week. By contrast, in patients
admitted to ICUs or discharged home after surgery, 30-day mor-
tality was not influenced by day of the week.33 Variation in the
outcomes of procedures performed during the day versus during
the night was studied by Uyarel et al., who found that percutane-
ous cardiac interventions can be safely performed at night in
high-volume centres.34 Similarly, in a large study of cardiac surgi-
cal procedures, postoperative morbidity and mortality were not
influenced by attending surgeon sleep hours.7
Pancreaticoduodenectomy is a procedure with multiple poten-
tial causes of morbidity, and in which pancreatic leaks and fistulae
have represented a major persistent source of complications since
the operation was first described.11,35 However, the mortality rate
has declined as a result of advances in surgical technique and
Table 5 Predictors of overall presence of any complications, leaks and fistulae, and 90-day mortality
Characteristics Any complications (n = 405) Any leaks or fistulae (n = 132) Death within 90 days (n = 29)
Univariate Multivariate Univariate Multivariate Univariate Multivariate
P-value OR 95% CI P-value P-value OR 95% CI P-value P-value OR 95% CI P-value
Age 0.638 – – – 0.474 – – – 0.013 1.03 0.98–1.07 0.180
Sex (male versus
female)
<0.001 1.48 1.10–1.97 0.009 <0.001 2.00 1.29–3.10 0.002 0.708 – – –
BMI (>25 kg/m2 versus
25 kg/m2)
0.017 1.23 0.91–1.66 0.174 0.024 1.09 0.69–1.71 0.707 0.239 – – –
Hypertension 0.485 – – – 0.635 – – – 0.708 – – –
Diabetes mellitus 0.790 – – – 0.398 – – – 0.474 – – –
Cardiac disease 0.025 1.31 0.93–1.84 0.119 0.431 – – – 0.003 2.03 0.89–4.58 0.090
Pulmonary disease 0.099 1.45 0.89–2.34 0.134 0.015 1.71 0.95-3.10 0.074 0.055 2.11 0.81–5.50 0.124
Other comorbidities 0.421 – – – 0.022 0.51 0.34–0.79 0.002 0.240 – – –
ASA class (3 or 4
versus 1 or 2)
0.208 – – – 0.028 1.63 1.06–2.50 0.025 0.001 2.09 0.77–5.62 0.144
Greatest diameter of
tumour
0.140 – – – 0.002 0.83 0.72–0.96 0.013 0.818 – – –
Malignant neoplasm
(yes versus no)
0.319 – – – 0.002 0.44 0.26–0.74 0.002 0.415 – – –
Duration of operation 0.005 1.00 0.99–1.00 0.231 0.010 1.00 0.99–1.00 0.492 0.446 – – –
Estimated blood loss
(100 ml)
0.001 1.03 1.01–1.06 0.017 <0.001 1.03 1.0–1.050 0.084 0.662 – – –
Any positive margin 0.109 – – – <0.001 0.13 0.03–0.53 0.005 0.803 – – –
Operation month 0.920 – – – 0.715 – – – 0.736 – – –
Operation day
(Mon–Wed versus
Thurs, Fri)
0.195 – – – 0.845 – – – 1.000 – – –
Operation start time
Before versus after
12.00 h
0.500 – – – 0.760 – – – 0.690 – – –
07.00–11.00 h 0.063 1.03 0.55–1.90 0.937 0.497 – – – 0.441 – – –
11.01–15.00 h 0.054 0.72 0.38–1.36 0.313 0.422 – – – 0.163 – – –
After 15.00 h 1.000 – – – 0.836 – – – 0.219 – – –
95% CI, 95% confidence interval; ASA, American Society of Anesthesiologists; BMI, body mass index; OR, odds ratio.
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perioperative management, increased volume and improved
patient selection. Pancreatic resections are now performed more
frequently in older patients with acceptable morbidity and mor-
tality rates and acceptable longterm survival in comparison with
younger patients. Obesity, as defined by BMI, has been considered
an important predictor of surgical outcome.36,37 Ramsey and
Martin published a meta-analysis of 17 retrospective studies con-
ducted during 1990–2010 and concluded that although BMI
increases the complexity of the operation and postoperative mor-
bidity, it does not affect mortality.38 In the present study, BMI was
not a factor in operative morbidity or mortality; however, it
should be highlighted that the interquartile range of BMI did not
vary much across the present cohort.
Pancreaticoduodenectomy is a highly technical operation per-
formed largely in specialized centres and although some rand-
omized controlled trials regarding technical aspects of the
procedure have been performed, data on outcomes specific to the
timing of the operation (i.e. time of day, day of the week, month
of the year) are scant. The strengths of the current study include
the homogeneity of its population, which was consecutively
managed in a single high-volume centre with a consistent surgical
oncology group, and the careful tracking of postoperative com-
plications. The endpoints were postoperative morbidity and
90-day mortality, and the study sought to identify variations
according to operation time, day or month.
Intraoperative and clinicopathological data analysis offered
interesting insights. Male gender was associated with increased
risks for complications, leaks and fistulae. Higher EBL was asso-
ciated with increased complications, probably reflecting greater
technical difficulty of the procedure. Interestingly, for every 1-cm
increase in tumour diameter, the presence of malignancy and
positive resection margins, the risk was significantly decreased,
possibly with reference to the degree of ductal dilatation, which
allows for a technically easier pancreatic anastomosis. The 1-day
extension in LoS subsequent to procedures performed after
12.00 h is likely to relate to the delay in initiating the standard
postoperative recovery regimen. Regarding 90-day mortality, the
multivariate analysis showed no association with gender, tumour
size, malignancy or EBL. The presence of cardiac and pulmonary
comorbid conditions was associated with borderline significance
to 90-day mortality, which correlates with the observation that
complications related to these two organ systems were associated
with the highest operative mortality rate. The duration of surgery
had no significance on rates of complications or mortality.
The major finding of this analysis was the lack of any associa-
tion between the timing of PD and perioperative morbidity of any
type, pancreatic leaks or fistulae, or 90-day mortality. The analysis
of perioperative outcome by month showed no evidence to
support the existence of a ‘July phenomenon’ with respect to this
operation performed at MSKCC. Furthermore, neither the surgi-
cal start time nor the day of the week had any significant impact
on the three outcome variables, and this was also true when cases
were stratified by individual surgeon.Although some variability in
morbidity and mortality rates was noted, and indeed was
expected, none of these differences were significant.
The results of the current study no doubt reflect the contribu-
tions and complex interplay of several factors. At the study insti-
tution, the surgical services are staffed with fellows who have
completed general surgical training, in addition to junior-level
housestaff. Whereas this somewhat greater experience of the
trainees helped to ensure consistency of patient care, other vari-
ables are very likely to have made greater and more profound
contributions, including the high-volume nature of the surgical
practice, the high degree of attending surgeon oversight, an infra-
structure of highly experienced nursing (floor nurses and nurse
practitioners) and ancillary personnel accustomed to managing
these patients after surgery, and appropriate patient selection. It is
important to recognize that the latter variables represent changes
that can be implemented at most centres.
The results of this study should not be misinterpreted as
endorsing the performance of an operation of this magnitude at
any time of the day.On the contrary,most of the operations in this
study were performed during the normal course of the operating
day and it is possible that resections that were anticipated to be
more difficult were purposely scheduled earlier. Nevertheless, the
results suggest that in selected patients, and in the hands of an
experienced surgical team, the timing of the operation does not
appear to affect perioperative outcome.
The limitations of the study are those associated with all retro-
spective studies. Additionally, although operative morbidity,
in-hospital and 90-day mortality, and LoS measures are widely
used perioperative outcome variables, these measures may not
fully assess other aspects of the care rendered, such as cost, long-
term functional outcome and patient satisfaction. Furthermore,
complications may have been underestimated if they occurred
after discharge, although major efforts were made to capture these
events and such ‘missed’ complications are likely to have repre-
sented a small fraction of the total morbidity.Although the sample
size was adequate to detect relatively small differences, and
patient-, operative- and disease-related variables were generally
evenly distributed between the complication and no-complication
groups, it is likely that case scheduling involved some degree of
prioritization based on the technical difficulty anticipated or asso-
ciated comorbid medical conditions. Although this must be rec-
ognized as a potential confounding influence, it should also be
recognized as a reflection of reasonable judgement by the operat-
ing surgeon. The fact that the current study is derived from a
specialized, tertiary care referral centre should not be viewed as
limiting its message. On the contrary, as the nature of surgical
training continues to evolve and complex surgical procedures are
increasingly limited to high-volume centres, this landscape will
become the norm and fluctuations in the quality of care based on
the time of day, day of the week or month of the year in which care
is delivered should not be expected.
In summary, the present study identified no association
between the timing of PD with respect to time of day, day of the
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week or month of the year, and perioperative outcome. Opera-
tions performed later in the day resulted in complication rates
similar to those found in operations performed earlier, as did
those performed at the end (i.e. on Fridays) compared with earlier
in the working week. Similarly, there was no evidence of a greater
incidence of complications at the beginning of the academic year
(i.e. in July and August) compared with the other months. These
findings are contrary to those of some previous studies that have
shown differences in the outcomes of operations based on timing
and scheduling, but some of these reports have suffered from a
heterogeneous patient mix, which makes the data difficult to
interpret. The present study was adequately powered to detect
relatively small differences and the results are therefore unlikely to
reflect a type II error.
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